ArticleFrontiers in oncology2025
Habitat-based radiomics for preoperative differentiation between early-stage serous borderline ovarian tumors and malignant ovarian tumors.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- CT-based habitat analysis combined with multi-channel deep learning for predicting early recurrence after pancreatic cancer resection: a multicenter study.Journal of translational medicine · 2026Article
- Predicting response to neoadjuvant chemotherapy combined with immunotherapy in gastric cancer based on habitat imaging and peritumoral radiomics: a two-center study.Journal of translational medicine · 2026Article
- A multicenter study: habitat imaging and radiomics to guide precision and individualized surgical treatment in chronic osteomyelitis.BMC medical imaging · 2026Article
- Habitat radiomics based on CT for assessing BRCA mutation status in patients with high-grade serous ovarian cancer: a multicenter study.Frontiers in oncology · 2026Article
- CT-based radiomics model for noninvasive prediction of progression-free survival in high-grade serous ovarian carcinoma: a multicenter study incorporating preoperative and postoperative clinical factors.BMC medical imaging · 2025Article
- Multiparametric-MRI habitat radiomics analysis for discriminating pathological types of brain metastases.Frontiers in oncology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: To evaluate the effectiveness of habitat-based radiomics in differentiating early-stage serous borderline ovarian tumors (SBOTs) from serous malignant ovarian tumors (SMOTs), thereby enhancing diagnostic precision and treatment strategies. Methods: We conducted a retrospective analysis of 210 patients with histopathologically confirmed SBOTs (n=95) and SMOTs (n=115) between December 2017 and February 2021. Multi-detector computed tomography images were obtained and analyzed using habitat-based radiomics, which segments tumors into distinct microenvironments based on Hounsfield Unit values. Clinical characteristics and imaging features were assessed, and predictive models were developed using logistic regression. Model performance was evaluated through receiver operating characteristic analysis, calibration curves, and decision curve analysis (DCA). Results: The habitat-based models, the Habitat2 and the combined model, demonstrated high area under the curve values of 0.960 and 0.957 in the training set, with similar performance observed in the validation set. Solid components of tumors were identified as key differentiators, with only one radiomics feature from cystic regions retained in the final model. DCA indicated that habitat-based models provided significant clinical utility. Conclusions: Habitat-based radiomics model was developed and validated for accurately preoperative differentiation between SBOTs and SMOTs, emphasizing the importance of solid tumor regions for accurate diagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.